NDC 68001-355

Palonosetron

Palonosetron

Palonosetron is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Bluepoint Laboratories. The primary component is Palonosetron Hydrochloride.

Product ID68001-355_4c971ec3-8bb4-42c3-8cb9-36270e2f95be
NDC68001-355
Product TypeHuman Prescription Drug
Proprietary NamePalonosetron
Generic NamePalonosetron
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2018-05-30
Marketing CategoryANDA / ANDA
Application NumberANDA201533
Labeler NameBluePoint Laboratories
Substance NamePALONOSETRON HYDROCHLORIDE
Active Ingredient Strength0 mg/mL
Pharm ClassesSerotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 68001-355-25

1 VIAL, SINGLE-USE in 1 CARTON (68001-355-25) > 5 mL in 1 VIAL, SINGLE-USE
Marketing Start Date2018-05-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68001-355-25 [68001035525]

Palonosetron INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA201533
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2018-05-30

Drug Details

Active Ingredients

IngredientStrength
PALONOSETRON HYDROCHLORIDE.05 mg/mL

OpenFDA Data

SPL SET ID:ee6f6f94-1ca7-481e-9909-b19ae64e80c2
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1728055
  • UPC Code
  • 0368001355254
  • Pharmacological Class

    • Serotonin 3 Receptor Antagonists [MoA]
    • Serotonin-3 Receptor Antagonist [EPC]

    NDC Crossover Matching brand name "Palonosetron" or generic name "Palonosetron"

    NDCBrand NameGeneric Name
    16714-834PalonosetronPalonosetron
    55111-694PalonosetronPalonosetron
    60505-6193PalonosetronPalonosetron Hydrochloride
    63323-673PalonosetronPalonosetron
    63323-942PalonosetronPalonosetron
    67184-0514PalonosetronPalonosetron Hydrochloride
    67184-0515PalonosetronPalonosetron Hydrochloride
    68001-355PalonosetronPalonosetron
    68001-482PalonosetronPalonosetron Hydrochloride

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.